DIA415.36+6.58 1.61%
SPX5,638.94+117.42 2.13%
IXIC17,754.09+451.07 2.61%

Earnings Scheduled For February 28, 2025

Benzinga·02/28/2025 08:32:09
Listen to the news

Companies Reporting Before The Bell

• Frontline (NYSE:FRO) is estimated to report quarterly earnings at $0.27 per share on revenue of $282.62 million.

• Nordic American Tankers (NYSE:NAT) is estimated to report quarterly earnings at $0.04 per share on revenue of $53.07 million.

• Fluent (NASDAQ:FLNT) is estimated to report quarterly loss at $0.23 per share on revenue of $68.06 million.

• Recursion Pharmaceuticals (NASDAQ:RXRX) is expected to report quarterly loss at $0.41 per share on revenue of $18.17 million.

• Oxford Square Cap (NASDAQ:OXSQ) is projected to report quarterly earnings at $0.06 per share on revenue of $9.90 million.

• Integral Ad Science (NASDAQ:IAS) is estimated to report quarterly earnings at $0.25 per share on revenue of $148.94 million.

• PAR Technology (NYSE:PAR) is estimated to report quarterly loss at $0.08 per share on revenue of $99.26 million.

• ANI Pharmaceuticals (NASDAQ:ANIP) is expected to report quarterly earnings at $0.31 per share on revenue of $175.12 million.

• TeraWulf (NASDAQ:WULF) is estimated to report quarterly loss at $0.02 per share on revenue of $37.36 million.

• Global Partners (NYSE:GLP) is estimated to report quarterly earnings at $0.90 per share on revenue of $5.80 billion.

• Rapid Micro Biosystems (NASDAQ:RPID) is expected to report quarterly loss at $0.22 per share on revenue of $7.60 million.

• FuboTV (NYSE:FUBO) is estimated to report quarterly loss at $0.11 per share on revenue of $444.91 million.

• Butterfly Network (NYSE:BFLY) is expected to report quarterly loss at $0.08 per share on revenue of $21.01 million.

• Natural Resources (NYSE:NRP) is projected to report earnings for its fourth quarter.

• Apellis Pharmaceuticals (NASDAQ:APLS) is expected to report quarterly loss at $0.37 per share on revenue of $191.93 million.

• Calumet (NASDAQ:CLMT) is estimated to report quarterly loss at $0.36 per share on revenue of $929.11 million.

• 1stdibs.com (NASDAQ:DIBS) is estimated to report quarterly earnings at $0.00 per share on revenue of $22.02 million.

• LandBridge (NYSE:LB) is projected to report quarterly earnings at $0.78 per share on revenue of $244.81 million.

• Fulgent Genetics (NASDAQ:FLGT) is estimated to report quarterly loss at $0.37 per share on revenue of $75.39 million.

• Owens & Minor (NYSE:OMI) is estimated to report quarterly earnings at $0.53 per share on revenue of $2.73 billion.

• Amneal Pharmaceuticals (NASDAQ:AMRX) is projected to report quarterly earnings at $0.15 per share on revenue of $700.83 million.

• Banco Latinoamericano (NYSE:BLX) is likely to report quarterly earnings at $0.44 per share on revenue of $251.03 million.

• Chart Industries (NYSE:GTLS) is expected to report quarterly earnings at $3.23 per share on revenue of $1.18 billion.

• Alpha Metallurgical (NYSE:AMR) is estimated to report quarterly earnings at $1.12 per share on revenue of $683.10 million.

• Docebo (NASDAQ:DCBO) is expected to report quarterly earnings at $0.27 per share on revenue of $56.24 million.

• Northwest Natural Hldg (NYSE:NWN) is expected to report quarterly earnings at $1.49 per share on revenue of $395.05 million.

Companies Reporting After The Bell

• BIT Mining (NYSE:BTCM) is estimated to report earnings for its fourth quarter.

• Monroe Cap (NASDAQ:MRCC) is expected to report quarterly earnings at $0.27 per share on revenue of $14.99 million.

• Longeveron (NASDAQ:LGVN) is projected to report quarterly loss at $0.36 per share on revenue of $660 thousand.

• Middlesex Water (NASDAQ:MSEX) is likely to report quarterly earnings at $0.37 per share on revenue of $45.00 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.